Neuroprotection of naloxone against ischemic injury in rats: Role of mu receptor antagonism

Neuroscience Letters

Volumn 345, Issue 3, 2003, Pages 169-172

  Liao, Su Lan ^a   Chen, Wen Yin ^a   Raung, Shue Ling ^a   Chen, Chun Jung ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Infarction; Naloxone; Neuroprotection; Opioid antagonist; Opioid peptide; Stroke

Indexed keywords

BETA FUNALTREXAMINE; CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MU OPIATE RECEPTOR; MYELOPEROXIDASE; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; BRAIN CORTEX; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG INFUSION; ENZYME ACTIVITY; MALE; MIDDLE CEREBRAL ARTERY; MOLECULAR INTERACTION; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; STATISTICAL SIGNIFICANCE; STEREOISOMERISM;

EID: 0037756715     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00540-8     Document Type: Article

References (20)

1. Baskin D.S., Widmayer M.A., Browning J.L., Heizer M.L., Schmidt W.K. Evaluation of delayed treatment of focal cerebral ischemia with three selective κ-opioid agonists in cats. Stroke. 25:1994;2047-2054.
2. Chatterjie N., Alexander G.J., Sechzer J.A., Lieberman K.W. Prevention of cocaine-induced hyperactivity by a naloxone isomer with no opiate antagonist activity. Neurochem. Res. 21:1996;691-693.
3. Chen C.J., Cheng F.C., Liao S.L., Chen W.N., Lin N.N., Kuo J.S. Effects of naloxone on lactate, pyruvate metabolism and antioxidant enzyme activity in rat cerebral ischemia/reperfusion. Neurosci. Lett. 287:2000;113-116.
4. Chen C.J., Liao S.L., Chen W.Y., Hong J.S., Kuo J.S. Cerebral ischemia/reperfusion injury in rat brain: effects of naloxone. NeuroReport. 12:2001;1245-1249.
5. Chen Y.T., Lin C.J., Lee A.Y., Chen J.S., Hwang D.S. Stereospecific blocking effects of naloxone against hemodynamic compromise and ventricular dysfunction due to myocardial ischemia and reperfusion. Int. J. Cardiol. 50:1995;125-129.
6. Chien G.L., Van-Winkle D.M. Naloxone blockade of myocardial ischemic preconditioning is stereoselective. J. Mol. Cell. Cardiol. 28:1996;1895-1900.
7. Choi D.W. Excitotoxic cell death. J. Neurobiol. 23:1992;1261-1276.
8. Faden A.I. Role of thyrotropin-releasing hormone and opiate receptor antagonists in limiting central nervous system injury. Adv. Neurol. 47:1988;531-546.
9. Fallis R.J., Fisher M., Lobo R.A. A double blind trial of naloxone in the treatment of acute stroke. Stroke. 15:1984;627-629.
10. Guéniau C., Oberlander C. The kappa opioid agonist Niravoline decreases brain edema in the mouse middle cerebral artery occlusion model of stroke. J. Pharmacol. Exp. Ther. 282:1997;1-6.
11. Iijima I., Minamikawa J.I., Jacobsen A.E., Brossi A., Rice K.E. Studies in the (+)-morphinin series-5. Synthesis and biological properties of (+)-naloxone. J. Med. Chem. 21:1978;398-400.
12. Itoh J., Ukai M., Kameyama T. Dynorphin A-(1-13) potently prevents memory dysfunctions induced by transient cerebral ischemia in mice. Eur. J. Pharmacol. 234:1993;9-15.
13. Jabaily J., Davis J.N. Naloxone administration to patients with acute stroke. Stroke. 15:1984;36-39.
14. Knapp P.E., Maderspach K., Hauser K.F. Endogenous opioid system in developing normal and jimpy oligodendrocytes. Glia. 22:1998;189-201.
15. Liu B., Du L., Hong J.S. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J. Pharmacol. Exp. Ther. 293:2000;607-617.
16. Liu Y., Qin L., Wilson B.C., An L., Hong J.S., Liu B. Inhibition by naloxone stereoisomers of β-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons. J. Pharmacol. Exp. Ther. 302:2002;1212-1219.
17. Roy S., Loh H. Effects of opioids on the immune system. Neurochem. Res. 21:1996;1375-1386.
18. Satoh M., Minami M. Molecular pharmacology of the opioid receptors. Pharmacol. Ther. 68:1995;343-364.
19. Zabramski J.M., Spetzler R.F., Selman R.S., Roessmann U.R., Hershey L.A., Crumrine R.C., Macko R. Naloxone therapy during focal cerebral ischemia. Evaluation in a primate model. Stroke. 15:1984;621-629.
20. Zhang J., Haddad G.G., Xia Y. δ-, but not μ- and κ-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury. Brain Res. 885:2000;143-153.